3D Bioprinting Market is Expected to Reach $3.3 billion | MarketsandMarkets.


Chicago, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In the near future, the 3D bioprinting industry is poised to revolutionize healthcare and scientific research. This cutting-edge technology holds the promise of creating functional, personalized organs, tissues, and implants, advancing regenerative medicine and reducing transplant waiting lists. With rapid advancements in materials science and biotechnology, 3D bioprinting will enable the production of intricate, patient-specific constructs with enhanced precision and biocompatibility, opening new frontiers in drug testing, disease modeling, and therapeutic interventions. As regulatory frameworks evolve and collaborative efforts flourish, the 3D bioprinting industry is on the cusp of reshaping the landscape of medicine and biotechnology, offering a glimpse into a future where custom-tailored, 3D-printed biological solutions become a routine part of healthcare and research.

3D Bioprinting market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $3.3 billion by 2027, growing at a CAGR of 20.8% from 2022 to 2027 according to a latest report published by MarketsandMarkets™. Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities drive the market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787

3D Bioprinting Market Scope:

Report Coverage Details
Market Revenue in 2022 $1.3 billion
Estimated Value by 2027 $3.3 billion
Growth Rate Poised to grow at a CAGR of 20.8%
Market Size Available for 2021-2027
Forecast Period 2022-2027
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Component, Material, Application, End user and Region
Geographies Covered North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Rising demand for organ transplants
Key Market Driver Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries

3D Bioprinting market major players covered in the report, such as:

  • BICO Group AB (US)
  • Organovo Holdings Inc. (US)
  • Allevi, Inc. (part of 3D Systems, Inc.) (US)
  • CollPlant Biotechnologies Ltd. (Israel)
  • regenHU (Switzerland)
  • EnvisionTEC GmbH (part of Desktop Metal) (Germany)
  • Aspect Biosystems Ltd. (Canada)
  • Advanced Solutions Life Sciences, LLC (US)
  • Cyfuse Biomedical K.K. (Japan)
  • ROKIT Healthcare, Inc. (South Korea)
  • Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China)
  • Pandorum Technologies Pvt. Ltd. (India)
  • Foldink Life Science Technologies (Armenia)
  • Revotek Co., Ltd. (US)
  • Precise Bio (US)
  • Brinter (Finland)
  • Prellis Biologics (US)
  • Regemat 3D (Spain)
  • 3DBio Therapeutics (US)
  • Tissue Regeneration Systems Inc. (US)
  • Poietis (France)
  • SunP Biotech, LLC (US)
  • Vivax Bio, LLC (US)
  • GeSiM mbH (Germany)
  • Manchester BIOGEL (UK)
  • and Among Others

Buy an 3D Bioprinting Industry Report (270 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=170201787

This report categorizes the 3D Bioprinting market into the following segments and subsegments:
               
3D Bioprinting Market, by Component

  • 3D Bioprinters
  • Bioinks 

3D Bioprinting Market, by Application

  • Research applications
  • Clinical applications

3D Bioprinting Market, by End user

  • Research Organizations and Academic Institutes,
  • Biopharmaceutical companies
  • Hospitals

3D Bioprinting Market, by region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170201787

The key stakeholders in the 3D Bioprinting market include:

  • Bioprinting Companies: These firms are at the forefront of developing and commercializing 3D bioprinting technologies, materials, and solutions.
  • Research Institutions: Universities, laboratories, and research centers play a vital role in advancing the science behind 3D bioprinting and conducting groundbreaking research in this field.
  • Healthcare Providers: Hospitals and medical centers are potential end-users of 3D bioprinted tissues and organs for transplantation and regenerative medicine applications.
  • Pharmaceutical Companies: The pharmaceutical industry can benefit from 3D bioprinting for drug testing and development, creating more physiologically relevant models.
  • Regulatory Agencies: Government agencies like the FDA (U.S.), which regulate medical devices and bioprinted products, are crucial stakeholders in ensuring safety and compliance.
  • Investors and Venture Capitalists: These entities provide funding to bioprinting companies and startups, facilitating innovation and market growth.
  • Patients and Patient Advocacy Groups: Patients in need of organ transplants or regenerative therapies have a vested interest in the development of 3D bioprinting solutions.
  • Material Suppliers: Companies supplying biomaterials, such as bioinks and biocompatible materials, are essential in enabling the bioprinting process.
  • Biotechnology and 3D Printing Equipment Manufacturers: Providers of 3D printers and bioprinting equipment are integral to the industry's growth.
  • Government Bodies and Policymakers: Government entities play a role in shaping the regulatory environment, funding research, and setting standards for 3D bioprinting.
  • Ethics and Bioethics Committees: These groups assess the ethical implications of bioprinting, particularly in relation to cloning, genetic engineering, and organ transplantation.
  • Non-Governmental Organizations (NGOs): Some NGOs advocate for responsible and equitable use of 3D bioprinting technologies and may provide support for related initiatives.

Educational Institutions: Schools and universities contribute to the training and education of the future workforce in bioprinting and related fields.

Recent Developments:

  • In March 2022, BICO Group AB (US) launched the BIO CELLX, which is a novel system that automates 3D cell culture workflows by leveraging prevalidated protocols.
  • In June 2021, 3D Systems, Inc. (US) and CollPlant Biotechnologies Ltd. (Israel) signed a co-development agreement for a 3D-bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant.

Frequently Asked Questions (FAQs) of 3D Bioprinting Market:

Question1. What is the impact of COVID-19 on the global 3D Bioprinting Market?
Answer: Companies scaled up R&D efforts to develop vaccines and drugs against the virus. Vaccine-related research activities in pharmaceutical and biotechnology companies, research centers, and academic research institutes are considered essential and largely unaffected operations and output. However, niche markets were sidelined due to the focus on COVID treatment-related research. 3D bioprinting was one such market. Thus, it experienced a slightly negative impact.

Question 2. Who are the key players in the 3D Bioprinting market?
Answer: Key players in the global 3D Bioprinting Market include BICO Group AB (US), Organovo Holdings Inc. (US), Allevi, Inc. (part of 3D Systems, Inc.) (US), CollPlant Biotechnologies Ltd. (Israel), regenHU (Switzerland), EnvisionTEC GmbH (part of Desktop Metal, Inc.) (Germany), Aspect Biosystems Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), and Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China).

Question 3: Which component segment dominates the 3D Bioprinting market?
Answer: In 2021, 3D bioprinters accounted for the larger market share in 2021. Factors such as technological advancements and the growing demand for organ transplants are driving the growth of this segment.       

Question 4: Which application segment of the 3D Bioprinting market is expected to witness the highest growth?
Answer: Research applications segment is expected to witness the highest growth during the forecast period. Increasing initiatives by market players and university scientists in the 3D bioprinting field is the major factor driving the growth of the research applications market.  

Question 5: What is the market size for the 3D Bioprinting market?
Answer: The global 3D Bioprinting market is estimated to grow from USD 1.3 billion in 2022 to reach USD 3.3 billion by 2027, at a CAGR of 20.8% during the forecast period.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170201787

Report Objectives:

  • To define, describe, and forecast the 3D bioprinting market on the basis of component, application, material, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall 3D bioprinting market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to five main regions, namely, North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, and the Rest of Asia Pacific), Latin America, and the Middle East & Africa.
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as product launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the 3D bioprinting market

Related Reports:

3D Cell Culture Market

Human Organoids Market

3D Printing Medical Devices Market

Biomaterials Market

4D Printing in Healthcare Market

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/3d-bioprinting-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/3d-bioprinting.asp

 

Contact Data